Re: Indirect Cost (F&A) Rates Charged on Clinical Trials Bivona and Kleinberg BML 21 Feb 2008 13:12 EST

We try to negotiate a 35% indirect rate for clinical trials, which is
different from our federally-approved rate.
_________________________________
Alicia Bivona & Jessica Kleinberg, CRA
Office of Sponsored Programs
Health Research, Inc.
One University Place
Rensselaer, NY 12144-3447

Phone: (518) 431-1264
Fax: (518) 431-1234
Email: xxxxxx@healthresearch.org

 "Bloomberg,
 Robert"
 <xxxxxx@TUFTS                                          To
 -NEMC.ORG>                xxxxxx@hrinet.org
 Sent by: Research                                          cc
 Administration
 List                                                  Subject
 <xxxxxx@hrinet.         Re: [RESADM-L] Indirect Cost (F&A)
 org>                      Rates Charged on Clinical Trials

 02/21/2008 12:38
 PM

 Please respond to
 Research
 Administration
 Discussion List
 <xxxxxx@hrinet.
 org>

In a related question, I would be interested in knowing if anyone is
charging a different rate for clinical trials than they charge for grants.

Thanks.
 -----Original Message-----
 From: Research Administration List [mailto:xxxxxx@hrinet.org]On
 Behalf Of Hudobenko,Paul F.
 Sent: Thursday, February 21, 2008 12:16 PM
 To: xxxxxx@hrinet.org
 Subject: [RESADM-L] Indirect Cost (F&A) Rates Charged on Clinical
 Trials

 We are considering revising the indirect cost rate that we charge to
 clinical trials. I would appreciate finding out what rates other
 institutions impose on these projects. Also, if anyone has recently
 changed their rate, has it had an effect on the number of trials
 and/or dollar volume of clinical trial funds received for your
 institution?

 All responses will be appreciated. You may respond off-list if you
 wish to my email address below. Thank you.

 Paul Hudobenko
 University of Connecticut Health Center
 xxxxxx@adp.uchc.edu

 ======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
 ======================================================================

======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available via
our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

IMPORTANT NOTICE:  This e-mail and any attachments may contain confidential or sensitive information which is, or may be, legally privileged or otherwise protected by law from further disclosure.  It is intended only for the addressee.  If you received this in error or from someone who was not authorized to send it to you, please do not distribute, copy or use it or any attachments.  Please notify the sender immediately by reply e-mail and delete this from your system. Thank you for your cooperation.

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================